Rachida Bourimi-Bouarich
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 15, 2025
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
Journal: NPJ precision oncology
Published: July 23, 2025
Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity.
Journal: Oncogene
Published: January 21, 2014
Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoires.
Journal: Transcription
Published: February 16, 2013
Mutant mice lacking the p53 C-terminal domain model telomere syndromes.
Journal: Cell reports
Published: December 20, 2012
Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival.
Journal: Oncogene
Published: October 19, 2012
Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes.
Journal: PLoS genetics
Published: November 23, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026